Geneva, July 1st, 2013.
Spineart accelerates its international development through its newly established German subsidiary.
Spineart announced today the opening of its German subsidiary, Spineart GmbH, effective July 1st 2013.
After 3 years of a successful and fruitful collaboration, Spineart and Sanofi-Aventis mutually agreed to terminate their exclusive distribution agreement in Germany. As part of the agreement Spineart Deutschland GmbH will progressively take over Sanofi Spine German distribution activities and sell directly in Germany, the largest European spine market. A transition period until the end of the year will allow a smooth and professional business transition.
In line with its strategy to address major markets, Spineart is now selling directly in the US, France, Switzerland, Italy, Austria and Germany with more announcements to be made before the end of the year.
About Spineart:
Spineart delivers pioneering, safe and efficient solutions to spine surgeons, operating room teams and patients.
Spineart, present in 47 countries, offers a full range of high quality Swiss Made Fusion, Motion, and MIS devices worldwide, focusing on simplicity and safety of use.
Spineart markets a complete portfolio of traceable barcoded sterile packed implants and is thereby proudly promoting higher safety, cost-efficiency, and compliance at the hospital.1